procarbazine has been researched along with Franklin Disease in 2 studies
Procarbazine: An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease.
procarbazine : A benzamide obtained by formal condensation of the carboxy group of 4-[(2-methylhydrazino)methyl]benzoic acid with the amino group of isopropylamine. An antineoplastic chemotherapy drug used for treatment of Hodgkin's lymphoma. Metabolism yields azo-procarbazine and hydrogen peroxide, which results in the breaking of DNA strands.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Takano, H | 1 |
Nagata, K | 1 |
Mikoshiba, M | 1 |
Nakane, M | 1 |
Kato, A | 1 |
Hamaguchi, H | 1 |
Schubert, JC | 1 |
2 other studies available for procarbazine and Franklin Disease
Article | Year |
---|---|
Combination of rituximab and chemotherapy showing anti-tumor effect in gamma heavy chain disease expressing CD20.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic | 2008 |
[Therapy of Waldenstrom's disease and of heavy chain disease].
Topics: Antineoplastic Agents; Bone Marrow; Bone Marrow Cells; Chlorambucil; Cyclophosphamide; Drug Therapy, | 1976 |